Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity
- 29 March 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 2 (6), 466-470
- https://doi.org/10.1021/ml200036r
Abstract
A set of nine 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamides and one 2,6-dimethylimidazo[1,2-a]pyrimidine-3-carboxamide were synthesized. The compounds were evaluated for their in vitro antituberculosis activity versus replicating, nonreplicating, multi- and extensive drug resistant Mtb strains. The MIC90 values of seven of these agents were ≤1 μM against the various tuberculosis strains tested. A representative compound of this class (1) was screened against seven nontubercular strains as well as other nonmycobacteria organisms and demonstrated remarkable microbe selectivity. A transcriptional profiling experiment of Mtb treated with compound 1 was performed to give a preliminary indication of the mode of action. Lastly, the in vivo ADME properties of compounds 1, 3, 4, and 6 were assessed. The 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxamides are a druglike and synthetically accessible class of anti-TB agents that have excellent selective potency against multi- and extensive drug resistant TB and encouraging pharmacokinetics.Keywords
This publication has 22 references indexed in Scilit:
- A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacyNature Communications, 2010
- Structure–activity relationship of new anti-tuberculosis agents derived from oxazoline and oxazole benzyl estersEuropean Journal of Medicinal Chemistry, 2010
- Gluconeogenic carbon flow of tricarboxylic acid cycle intermediates is critical for Mycobacterium tuberculosis to establish and maintain infectionProceedings of the National Academy of Sciences of the United States of America, 2010
- Utilization of the Suzuki Coupling to Enhance the Antituberculosis Activity of AryloxazolesHETEROCYCLES, 2010
- Functionalized 3-amino-imidazo[1,2-a]pyridines: A novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral HospitalClinical Infectious Diseases, 2008
- Low-Oxygen-Recovery Assay for High-Throughput Screening of Compounds against Nonreplicating Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2007
- In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2005
- Fused Heterocycles: Synthesis of Some New Imidazo[1,2-a]- pyridine DerivativesMolecules, 2004
- Regiospecific Synthesis of 3-Substituted Imidazo[1,2-a]pyridines, Imidazo[1,2-a]pyrimidines, and Imidazo[1,2-c]pyrimidineThe Journal of Organic Chemistry, 2003